OLPX: Takeover Talks And Margin Resilience Will Support Future Upside

Analysts have trimmed their average price target on Olaplex Holdings to $2.50 from $4.00. This change reflects more cautious assumptions on revenue growth and valuation multiples, even as margin expectations are adjusted upward.

Analyst Commentary

Recent research on Olaplex points to a more balanced stance, with some analysts focusing on potential execution upside and others stressing valuation and growth constraints. The latest move to a US$2.50 price target captures this mixed view.

Bullish Takeaways

Bullish analysts see room for margin resilience, which could support earnings quality even if top line trends remain under pressure.
The US$2.50 target is framed as consistent with an In Line rating, suggesting current valuation is not viewed as stretched relative to perceived fundamentals.
Some prior target increases, even if modest, signal that a portion of the Street is open to revisiting assumptions if execution improves.
The presence of multiple Hold or equivalent ratings points to a view that, at current levels, downside may be more limited than when targets were higher.

Bearish Takeaways

Bearish analysts highlight reduced confidence in revenue trajectories, which feeds directly into the cut in the average price target to US$2.50.
The shift in targets suggests less willingness to pay higher valuation multiples without clearer evidence of sustained growth.
Neutral or Hold style ratings, combined with lower targets, indicate concern that execution risks and competitive pressures could cap upside.
The move from a US$4.00 to US$2.50 average target underscores that expectations for re-rating have become more conservative, with greater focus on proof of performance before assigning richer multiples.

What's in the News

Henkel is reported to have submitted a takeover offer for Olaplex, with the two companies said to be in talks about a potential deal that could come together within weeks (Bloomberg).
Advent is identified as Olaplex's largest shareholder, with close to 75% ownership, in the context of the reported takeover discussions (Bloomberg).
Following the initial takeover report, Olaplex shares moved to $1.67, described as a 24% jump, or US$0.32, on the day of the news (Bloomberg).
Olaplex issued fiscal 2026 net sales guidance in a range of US$414m to US$435m, with management indicating that net sales for the first quarter are expected to be below the full year run rate on a percentage basis.
Olaplex launched No.3PLUS Complete Repair Treatment, described as a pre shampoo treatment featuring the company's Bond Building Technology and a new Damage Defense Cationic Complex, supported by a "Science Never Looked So Good" marketing campaign and distribution across OLAPLEX.com and multiple retail and professional channels.

Valuation Changes

Fair Value: $1.92 has been revised slightly lower to $1.85, indicating a modest reset in the central valuation estimate.
Discount Rate: The discount rate has moved from 8.14% to 7.76%, a small reduction that increases the present value placed on future cash flows.
Revenue Growth: Revenue growth assumptions have been scaled back from 2.93% to 1.36%, reflecting a more cautious outlook on future sales expansion.
Net Profit Margin: Net profit margin has been lifted from 11.01% to 13.38%, pointing to higher expected profitability on each $ of sales.
Future P/E: The future P/E multiple has come down from 32.64x to 26.68x, implying a lower valuation being applied to projected earnings.

24 views

Key Takeaways

Expanding product innovation and professional partnerships are enhancing market share, brand reputation, and customer loyalty across both retail and salon channels.
Strengthened digital, international, and direct-to-consumer strategies are unlocking scalable growth, broadening global reach, and improving margins through efficient customer engagement.
Structural retail weakness, margin pressure, early-stage transformation risks, changing consumer hair trends, and rising competition threaten Olaplex's growth, profitability, and market position.

Catalysts

About Olaplex Holdings

Through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally.What are the underlying business or industry changes driving this perspective?

Olaplex's accelerated new product development-launching three innovations including entry into the fast-growing scalp health segment-positions the company to increase repeat purchases, capture incremental market share, and support revenue growth and margin expansion through proprietary, science-backed offerings.
The revitalized global brand campaign, updated digital storytelling, and strengthened direct-to-consumer capabilities (e.g., revamped website, focused promotional cadence, and enhanced data/AI tools) are unlocking scalable e-commerce opportunities and lowering customer acquisition costs, supporting topline growth and operating margin improvement.
Strategic investment in international expansion-including a new office in London, tailored market approaches, and systematic distributor rationalization-is expected to drive increased global penetration and geographic diversification, stabilizing and growing revenues over the long term.
Heightened professional channel engagement via educational programs, Pro ambassador events, and salon-exclusive service launches is reinforcing Olaplex's reputation with stylists, leveraging influential endorsements to drive both professional and retail sales, positively impacting revenue and repeat business.
Olaplex's alignment with rising consumer preferences for wellness, premiumization, and scientifically proven beauty solutions (as evidenced by strong social media engagement and campaign metrics) reinforces brand relevance and pricing power, supporting sustained growth and healthy net margins.

Olaplex Holdings Earnings and Revenue Growth

Olaplex Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Olaplex Holdings's revenue will grow by 1.4% annually over the next 3 years.
Analysts assume that profit margins will increase from -2.2% today to 13.4% in 3 years time.
Analysts expect earnings to reach $58.9 million (and earnings per share of $0.06) by about March 2029, up from -$9.3 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $128.0 million in earnings, and the most bearish expecting $23.3 million.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 26.7x on those 2029 earnings, up from -94.1x today. This future PE is greater than the current PE for the US Personal Products industry at 21.9x.
Analysts expect the number of shares outstanding to grow by 0.52% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.76%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Specialty retail sales continue to decline (down 16.7% year-over-year in the quarter and 3% year-to-date), indicating ongoing structural weakness or shifting consumer preferences away from brick-and-mortar, which could pressure overall revenues and hamper future sales recovery.
Margin erosion is evident, with EBITDA margins dropping from 33.3% year-to-date last year to 24.7%, driven by increased investments in marketing, innovation, and talent-suggesting that, unless revenue growth accelerates, profit and net margins could remain under pressure for a prolonged period.
The company remains highly reliant on a transformation strategy that is still "mid-build" and in early execution phases, raising long-term risks related to execution, timing, and the uncertainty of whether these initiatives will yield consistent and sustainable revenue or earnings growth.
Olaplex is exposed to shifts in hair care trends and consumer behaviors-such as the movement toward "lower maintenance" and "more natural hair color," which reduces salon visit frequency and directly impacts sales in its core professional channel, undermining top-line growth potential.
Heightened competition in the prestige and "science-backed" hair-care sector, combined with a limited SKU/product portfolio, increases the risk that Olaplex could lose market share or pricing power to emerging or larger rivals, negatively affecting future revenues, gross margins, and earnings stability.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $1.85 for Olaplex Holdings based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $2.5, and the most bearish reporting a price target of just $1.4.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $440.4 million, earnings will come to $58.9 million, and it would be trading on a PE ratio of 26.7x, assuming you use a discount rate of 7.8%.
Given the current share price of $1.3, the analyst price target of $1.85 is 29.7% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Olaplex Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

New Product Launch And Global Expansion Will Unlock Opportunities